2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow lanifibranor: new trials by email Literature Review of lanifibranor trials Research Report on lanifibranor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pharmacokinetic Study of Lanifibranor in Healthy Adult Chinese Subjects Lanifibranor - Pharmacokinetic | Phase 1 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 24 | 2023-10-31 | 2024-01-02 |
| Multiple Ascending Dose Phase I Study in Order to Define Lanifibranor (IVA337) Supra-thjerapeutic Dose Moxifloxacin, Placebo, Lanifibranor - Healthy Subjects | Phase 1 | Completed | Inventiva Pharma | 36 | 2019-01-17 | 2019-11-01 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Inventiva Pharma (1)
China (1) · Germany (1)
2018 (1)